A Clinical Trial of the Administration of Light Therapy to Prevent Mouth Sores in Children With Cancer

Part of paid clinical trials in Milwaukee, Wisconsin.

Sponsor
Medical College of Wisconsin
Study ID
NCT06623305
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Mucositis Oral

Eligibility Criteria

Sex
ALL
Age
N/A - 30 Years
Healthy Volunteers
Not accepted

Interventions

  • Photobiomodulation for prevention arm — DEVICE
    Light therapy will be administered using the cluster probe on the external cheeks bilaterally and intraorally using the lollipop probe for patients ≥7 years of age. Patients \<7 years of age will not receive intraoral treatment with the lollipop. Instead, they will be asked to open their mouth while the covered cluster probe is held externally to treat their intraoral membranes. Each treatment (both external cheeks and intraoral buccal region) will be administered over 1 min with a Modulation Frequency 2.5Hz, Skin Conduction nS 001, and Beam Power mW 000, for a total treatment time of 3 minutes. Patients will continue to receive light therapy in the home setting through day +8 of their chemotherapy cycle using the Luminance Device.
  • Photobiomodulation for exploratory arm — DEVICE
    Light therapy will be administered using the cluster probe on the external cheeks bilaterally and intraorally using the lollipop probe for patients ≥7 years of age. Patients \<7 years of age will not receive intraoral treatment with the lollipop. Instead, they will be asked to open their mouth while the covered cluster probe is held externally to treat their intraoral membranes. Each treatment (both external cheeks and intraoral buccal region) will be administered over 1 min with a Modulation Frequency 2.5Hz, Skin Conduction nS 001, and Beam Power mW 000, for a total treatment time of 3 minutes. Patients will continue to receive light therapy in the home setting through day +8 of their chemotherapy cycle using the Luminance Device.

Study Details

The goal of this clinical trial is to learn if light therapy can prevent mouth sores in children with cancer. The main questions it aims to answer are: Is it reasonable and acceptable to provide light therapy for children with cancer? Does light therapy prevent mouth sores related to medical treatment? Researchers will compare children who do not receive light therapy to children who do receive light therapy during the clinical trial to see if light therapy helps to prevent mucositis. Participants will: * Complete a survey. * Have picture taken of their mouth to look for mouth sores. * Receive light therapy every day while admitted to the hospital on the cancer unit or while admitted to an alternate unit, and continue to receive light therapy in the home setting until they reach 8 days after the start of their chemotherapy cycle.

Key Dates

First listed
Oct 2, 2024
Start date
Aug 31, 2026
Status verified
Jun 2026
Primary completion
Aug 31, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
50 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • No Intervention: Control Arm
    Prospective data review of patients who did not receive light therapy
  • Active Comparator: Prevention Arm
    Prospective data review of patients who did receive light therapy
  • Active Comparator: Exploratory Arm
    Prospective review of patients with Trisomy 21 who did receive light therapy

Primary Outcome Measure

Evaluate the feasibility of using PBM in pediatric oncology patients. [ Time Frame: From date of enrollment until date of last PBM treatment, assessed up to 2 years. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Medical College of WisconsinMilwaukeeWisconsin53226
Elissa Shulta, DNP
414-266-5407
Peter Shaw, MD
414-955-4086
Peter Shaw, MD (SUB_INVESTIGATOR)
Valerie Lohse, MSN (SUB_INVESTIGATOR)
Sarah Joost, MSN (SUB_INVESTIGATOR)
Elissa Shulta, DNP (PRINCIPAL_INVESTIGATOR)
Meredith Beversdorf, BSN (SUB_INVESTIGATOR)
Amberley Kemic, BSN (SUB_INVESTIGATOR)
Ashley Hain, BSN (SUB_INVESTIGATOR)
Amy Pan, PhD (SUB_INVESTIGATOR)

Find similar trials in Milwaukee, WI

Related Studies